CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,652,475 | -19.1% | 102,500 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $5,754,350 | -12.3% | 102,500 | -29.4% | 0.01% | 0.0% |
| Q1 2023 | $6,562,873 | -38.4% | 145,100 | -44.7% | 0.01% | -50.0% |
| Q4 2022 | $10,662,495 | -7.2% | 262,300 | +49.1% | 0.01% | -14.3% |
| Q3 2022 | $11,495,000 | -8.1% | 175,900 | -14.6% | 0.01% | 0.0% |
| Q2 2022 | $12,512,000 | -15.4% | 205,900 | -12.6% | 0.01% | 0.0% |
| Q1 2022 | $14,783,000 | +19.6% | 235,520 | +44.4% | 0.01% | +55.6% |
| Q4 2021 | $12,358,000 | +11.9% | 163,072 | +65.2% | 0.01% | -10.0% |
| Q3 2021 | $11,048,000 | -47.1% | 98,696 | -23.4% | 0.01% | -44.4% |
| Q2 2021 | $20,868,000 | -19.5% | 128,898 | -39.4% | 0.02% | -28.0% |
| Q1 2021 | $25,917,000 | -44.2% | 212,692 | -29.8% | 0.02% | -40.5% |
| Q4 2020 | $46,415,000 | +86.9% | 303,151 | +2.1% | 0.04% | +61.5% |
| Q3 2020 | $24,830,000 | -5.8% | 296,867 | -17.2% | 0.03% | -18.8% |
| Q2 2020 | $26,355,000 | +117.4% | 358,624 | +25.5% | 0.03% | +68.4% |
| Q1 2020 | $12,124,000 | +966.3% | 285,859 | +1431.4% | 0.02% | +850.0% |
| Q4 2019 | $1,137,000 | +38.2% | 18,667 | -7.1% | 0.00% | +100.0% |
| Q3 2019 | $823,000 | +148.6% | 20,084 | +186.1% | 0.00% | – |
| Q2 2019 | $331,000 | +41.5% | 7,019 | +7.1% | 0.00% | – |
| Q1 2019 | $234,000 | -85.0% | 6,552 | -88.0% | 0.00% | -100.0% |
| Q4 2018 | $1,563,000 | +538.0% | 54,712 | +888.5% | 0.00% | – |
| Q3 2018 | $245,000 | -26.6% | 5,535 | -2.7% | 0.00% | – |
| Q2 2018 | $334,000 | -54.3% | 5,687 | -64.4% | 0.00% | -100.0% |
| Q1 2018 | $731,000 | – | 15,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |